肾脏疾病
透析
医学
指南
随机对照试验
急诊科
人口
心理干预
急诊医学
相对风险
重症监护医学
糖尿病
危险系数
干预(咨询)
置信区间
内科学
护理部
环境卫生
病理
内分泌学
作者
Miguel Vazquez,Gretchen D. Oliver,Ruben Amarasingham,Venkatraghavan Sundaram,Kevin Chan,Chul Ahn,Song Zhang,Perry Bickel,Samir M. Parikh,Barbara L. Wells,R. Tyler Miller,S. Susan Hedayati,Jeffrey L. Hastings,Adeola Jaiyeola,Tuan‐Minh Nguyen,Brett Moran,Noel Santini,Blake Barker,Ferdinand Velasco,Lynn B. Myers,Thomas P. Meehan,Chester H. Fox,Robert D. Toto
标识
DOI:10.1056/nejmoa2311708
摘要
Despite the availability of effective therapies for patients with chronic kidney disease, type 2 diabetes, and hypertension (the kidney-dysfunction triad), the results of large-scale trials examining the implementation of guideline-directed therapy to reduce the risk of death and complications in this population are lacking.
科研通智能强力驱动
Strongly Powered by AbleSci AI